Adebelimumab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Adebelimumab, covering 2024-08-09 to 2025-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of SHR-A1811 Combined With Adebelimumab as Neoadjuvant Therapy for Resectable HER2-Altered Non-Small Cell Lung Cancer [Phase 2]